Long-term safety of pregnancy following breast cancer according to estrogen receptor status

Matteo Lambertini, Niels Kroman, Lieveke Ameye, Octavi Cordoba, Alvaro Pinto, Giovanni Benedetti, Maj Britt Jensen, Shari Gelber, Maria Del Grande, Michail Ignatiadis, Evandro De Azambuja, Marianne Paesmans, Fedro A. Peccatori, Hatem A. Azim

Research output: Contribution to journalArticle

Abstract

Safety of pregnancy in women with history of estrogen receptor (ER)–positive breast cancer remains controversial. In this multicenter case–control study, 333 patients with pregnancy after breast cancer were matched (1:3) to 874 nonpregnant patients of similar characteristics, adjusting for guaranteed time bias. Survival estimates were calculated using the Kaplan-Meier analysis; groups were compared with the log-rank test. All reported P values were two-sided. At a median follow-up of 7.2 years after pregnancy, no difference in disease-free survival was observed between pregnant and nonpregnant patients with ER-positive (hazard ratio [HR] ¼ 0.94, 95% confidence interval [CI] ¼ 0.70 to 1.26, P ¼ .68) or ER-negative (HR ¼ 0.75, 95% CI ¼ 0.53 to 1.06, P ¼ .10) disease. No overall survival (OS) difference was observed in ER-positive patients (HR ¼ 0.84, 95% CI ¼ 0.60 to 1.18, P ¼ .32); ER-negative patients in the pregnant cohort had better OS (HR ¼ 0.57, 95% CI ¼ 0.36 to 0.90, P ¼ .01). Abortion, time to pregnancy, breastfeeding, and type of adjuvant therapy had no impact on patients’ outcomes. This study provides reassuring evidence on the long-term safety of pregnancy in breast cancer survivors, including those with ER-positive disease.

Original languageEnglish
Pages (from-to)426-429
Number of pages4
JournalJournal of the National Cancer Institute
Volume110
Issue number4
DOIs
Publication statusPublished - Apr 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Long-term safety of pregnancy following breast cancer according to estrogen receptor status'. Together they form a unique fingerprint.

  • Cite this

    Lambertini, M., Kroman, N., Ameye, L., Cordoba, O., Pinto, A., Benedetti, G., Jensen, M. B., Gelber, S., Del Grande, M., Ignatiadis, M., De Azambuja, E., Paesmans, M., Peccatori, F. A., & Azim, H. A. (2018). Long-term safety of pregnancy following breast cancer according to estrogen receptor status. Journal of the National Cancer Institute, 110(4), 426-429. https://doi.org/10.1093/jnci/djx206